IDH1 and glioblastoma: The same changes were noted regardless of whether the GBM samples assessed were derived from primary, de novo GBM (as defined by lack of IDH mutation, Gr-IV-p), IDH mutant secondary GBM that arose from lower grade gliomas (Gr-IV-s)[26], or GBM cells in culture.